In silico designed novel multi epitope vaccine construct towards Bundibugyo Ebolavirus
The aim of this research is to develop a protein-based vaccine for immunization against the
Ebola virus disease (EVD) using immunological information and knowledge of structural
biology. According to WHO reports the fatality rate of the EVD is around 67% in the year
2019. Particularly, the Bundibugyo Ebolaviruses has the least pathogenic fatality rate
approximately around 37%. Moreover, in past outbreaks, the fatality rate is different from 25
to 95% due to a shortage of powerful medication and vaccines. In this present work …
Ebola virus disease (EVD) using immunological information and knowledge of structural
biology. According to WHO reports the fatality rate of the EVD is around 67% in the year
2019. Particularly, the Bundibugyo Ebolaviruses has the least pathogenic fatality rate
approximately around 37%. Moreover, in past outbreaks, the fatality rate is different from 25
to 95% due to a shortage of powerful medication and vaccines. In this present work …
以上显示的是最相近的搜索结果。 查看全部搜索结果